Abstract | BACKGROUND: METHODS: RESULTS: Of the 60 patients included, 3 exclusions occurred for conversion to open surgery. There were no differences between groups in pain scores or in morphine consumption. No patients in the nebulization group presented significant shoulder pain in comparison with 83% of patients in the instillation group (absolute risk reduction -83, 95% CI -97 to -70, P<0.001). Nineteen (70%) patients receiving nebulization walked without assistance within 12 hours after surgery in comparison with 14 (47%) patients receiving instillation (absolute risk reduction -24, 95% CI -48 to 1, P=0.04). One (3%) patient in the instillation group vomited in comparison with 6 (22%) patients in the nebulization group (absolute risk reduction -19%, 95% CI -36 to -2, P=0.03). CONCLUSIONS:
|
Authors | Mario Bucciero, Pablo M Ingelmo, Roberto Fumagalli, Eric Noll, Andrea Garbagnati, Marta Somaini, Girish P Joshi, Giovanni Vitale, Vittorio Giardini, Pierre Diemunsch |
Journal | Anesthesia and analgesia
(Anesth Analg)
Vol. 113
Issue 5
Pg. 1266-71
(Nov 2011)
ISSN: 1526-7598 [Electronic] United States |
PMID | 21918162
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amides
- Analgesics, Opioid
- Anesthetics, Local
- Morphine
- Ropivacaine
|
Topics |
- Adolescent
- Adult
- Aged
- Amides
(administration & dosage, therapeutic use)
- Analgesics, Opioid
(therapeutic use)
- Anesthesia Recovery Period
- Anesthesia, General
- Anesthetics, Local
(administration & dosage, therapeutic use)
- Cholecystectomy, Laparoscopic
- Double-Blind Method
- Early Ambulation
- Endpoint Determination
- Female
- Humans
- Infusions, Parenteral
- Length of Stay
- Male
- Middle Aged
- Morphine
(therapeutic use)
- Nebulizers and Vaporizers
- Pain Measurement
(drug effects)
- Pain, Postoperative
(drug therapy)
- Postoperative Nausea and Vomiting
(epidemiology)
- Ropivacaine
- Shoulder Pain
(prevention & control)
- Young Adult
|